Rekrutierende Studie = ; Fortlaufende Studie = ; Abgeschlossene Studie = ; Förderung durch ein IRDiRC-Mitglied = ; ERN-Mitglied =

Nationale klinische Studie(n)

NIEDERLANDE

Noord-Holland
AMSTERDAM

The Drug Rediscovery Protocol (DRUP trial): A Dutch National Study on behalf of the Center for Personalized Cancer Treatment (CPCT) to Facilitate Patient Access to Commercially Available, Targeted Anti-cancer Drugs to determine the Potential Efficacy in Treatment of Advanced Cancers with a Known Molecular Profile (Phase II)

Het Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis

Afdeling Maag-Darm-Leveroncologie

Mehr Details

BELGIEN

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

STEP: Sorafenib Long Term Extension Program - BE

Cliniques universitaires Saint-Luc - UCLouvain

Pneumologie_Oncologie thoracique

Mehr Details

ITALIEN

LAZIO
ROMA

An Open-Label, Single-Arm, Phase 1/2 Study Evaluating the Safety and Efficacy of Ponatinib for the Treatment of Recurrent or Refractory Leukemias or Solid Tumors in Pediatric Participants - IT

IRCCS Ospedale Pediatrico Bambino Gesù - SEDE GIANICOLO

U.O. di Oncoematologia

Mehr Details